Financhill
Sell
41

PFE Quote, Financials, Valuation and Earnings

Last price:
$27.57
Seasonality move :
2.4%
Day range:
$27.55 - $27.94
52-week range:
$20.92 - $27.94
Dividend yield:
6.24%
P/E ratio:
20.35x
P/S ratio:
2.51x
P/B ratio:
1.69x
Volume:
37M
Avg. volume:
52.4M
1-year change:
7.57%
Market cap:
$156.8B
Revenue:
$62.6B
EPS (TTM):
$1.36
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $81.3B $100.3B $59.6B $63.6B $62.6B
Revenue Growth (YoY) 95.17% 23.43% -40.64% 6.84% -1.65%
 
Cost of Revenues $34.4B $38.2B $29.2B $21.8B $16.1B
Gross Profit $46.9B $62.1B $30.3B $41.8B $46.5B
Gross Profit Margin 57.67% 61.89% 50.95% 65.77% 74.33%
 
R&D Expenses $13.8B $11.4B $10.6B $10.7B $10.4B
Selling, General & Admin $12.7B $13.7B $14.8B $14.7B $13.8B
Other Inc / (Exp) $5.3B -$1.4B -$2.6B -$4.3B --
Operating Expenses $26.1B $24.5B $25B $25.4B $29.1B
Operating Income $20.8B $37.5B $5.3B $16.5B $17.4B
 
Net Interest Expenses $1.3B $1.2B $2.2B $3.1B $2.7B
EBT. Incl. Unusual Items $24.3B $34.7B $1.1B $8B $7.5B
Earnings of Discontinued Ops. -$434M $6M -$15M $11M $25M
Income Tax Expense $1.9B $3.3B -$1.1B -$28M -$266M
Net Income to Company $22B $31.4B $2.2B $8.1B --
 
Minority Interest in Earnings $45M $35M $39M $31M $41M
Net Income to Common Excl Extra Items $22.5B $31.4B $2.2B $8.1B $7.8B
 
Basic EPS (Cont. Ops) $3.95 $5.59 $0.38 $1.42 $1.37
Diluted EPS (Cont. Ops) $3.88 $5.47 $0.37 $1.41 $1.36
Weighted Average Basic Share $5.6B $5.6B $5.6B $5.7B $5.7B
Weighted Average Diluted Share $5.7B $5.7B $5.7B $5.7B $5.7B
 
EBITDA $26B $42.6B $11.6B $23.5B --
EBIT $20.8B $37.5B $5.3B $16.5B $17.4B
 
Revenue (Reported) $81.3B $100.3B $59.6B $63.6B $62.6B
Operating Income (Reported) $20.8B $37.5B $5.3B $16.5B $17.4B
Operating Income (Adjusted) $20.8B $37.5B $5.3B $16.5B $17.4B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $23.8B $24.3B $14.6B $17.8B $17.6B
Revenue Growth (YoY) 104.9% 1.9% -40.02% 21.92% -1.16%
 
Cost of Revenues $10.7B $10.9B $8.6B $4.8B $5.3B
Gross Profit $13.2B $13.4B $6B $13B $12.3B
Gross Profit Margin 55.21% 55.13% 41.04% 73.01% 69.97%
 
R&D Expenses $5.9B $3.6B $2.8B $3B $3.2B
Selling, General & Admin $4.1B $4.6B $4.6B $4.3B $4.2B
Other Inc / (Exp) $1B -$615M -$2.3B -$2.5B --
Operating Expenses $9.9B $8B $7.2B $7.2B $8.6B
Operating Income $3.3B $5.3B -$1.3B $5.7B $3.7B
 
Net Interest Expenses $315M $313M $689M $739M $711M
EBT. Incl. Unusual Items $3.8B $5.2B -$4.1B -$10M -$1.6B
Earnings of Discontinued Ops. -$187M $2M -$26M $7M --
Income Tax Expense $249M $230M -$794M -$421M -$2M
Net Income to Company $3.4B $5B -$3.4B $418M --
 
Minority Interest in Earnings -$2M $8M $8M $8M $8M
Net Income to Common Excl Extra Items $3.6B $5B -$3.3B $411M -$1.6B
 
Basic EPS (Cont. Ops) $0.60 $0.89 -$0.59 $0.07 -$0.29
Diluted EPS (Cont. Ops) $0.59 $0.87 -$0.59 $0.07 -$0.29
Weighted Average Basic Share $5.6B $5.6B $5.6B $5.7B $5.7B
Weighted Average Diluted Share $5.8B $5.7B $5.6B $5.7B $5.7B
 
EBITDA $4.6B $6.9B $407M $7.5B --
EBIT $3.3B $5.3B -$1.3B $5.7B $3.7B
 
Revenue (Reported) $23.8B $24.3B $14.6B $17.8B $17.6B
Operating Income (Reported) $3.3B $5.3B -$1.3B $5.7B $3.7B
Operating Income (Adjusted) $3.3B $5.3B -$1.3B $5.7B $3.7B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $81.3B $100.3B $59.6B $63.6B $62.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $34.4B $37.8B $29.7B $21.1B $19.9B
Gross Profit $46.9B $62.6B $29.8B $42.5B $42.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $12.8B $11.4B $10.6B $10.7B $10.3B
Selling, General & Admin $12.7B $13.7B $14.8B $14.7B $13.8B
Other Inc / (Exp) $5.3B -$1.4B -$2.6B -$4.3B --
Operating Expenses $25.1B $24.5B $25B $25.3B $25.3B
Operating Income $21.8B $38B $4.8B $17.1B $17.4B
 
Net Interest Expenses $1.3B $1.2B $2.2B $3.1B $2.7B
EBT. Incl. Unusual Items $24.3B $34.7B $1.1B $8B $7.5B
Earnings of Discontinued Ops. -$435M $6M -$15M $11M $25M
Income Tax Expense $1.9B $3.3B -$1.1B -$28M -$266M
Net Income to Company $22B $31.4B $2.2B $8.1B --
 
Minority Interest in Earnings $45M $35M $38M $31M $41M
Net Income to Common Excl Extra Items $22.5B $31.4B $2.2B $8.1B $7.8B
 
Basic EPS (Cont. Ops) $3.97 $5.59 $0.38 $1.42 $1.36
Diluted EPS (Cont. Ops) $3.90 $5.47 $0.36 $1.41 $1.36
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $27B $43.1B $11.1B $24.1B --
EBIT $21.8B $38B $4.8B $17.1B $17.4B
 
Revenue (Reported) $81.3B $100.3B $59.6B $63.6B $62.6B
Operating Income (Reported) $21.8B $38B $4.8B $17.1B $17.4B
Operating Income (Adjusted) $21.8B $38B $4.8B $17.1B $17.4B
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Revenue $100.3B $59.6B $63.6B $62.6B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $37.8B $29.7B $21.1B $19.9B --
Gross Profit $62.6B $29.8B $42.5B $42.7B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $11.4B $10.6B $10.7B $10.3B --
Selling, General & Admin $13.7B $14.8B $14.7B $13.8B --
Other Inc / (Exp) -$1.4B -$2.6B -$4.3B -$1.3B --
Operating Expenses $24.5B $25B $25.3B $25.3B --
Operating Income $38B $4.8B $17.1B $17.4B --
 
Net Interest Expenses $1.2B $2.2B $3.1B $2.7B --
EBT. Incl. Unusual Items $34.7B $1.1B $8B $7.5B --
Earnings of Discontinued Ops. $6M -$15M $11M $25M --
Income Tax Expense $3.3B -$1.1B -$28M -$266M --
Net Income to Company $31.4B $2.2B $8.1B $9.4B --
 
Minority Interest in Earnings $35M $38M $31M $41M --
Net Income to Common Excl Extra Items $31.4B $2.2B $8.1B $7.8B --
 
Basic EPS (Cont. Ops) $5.59 $0.38 $1.42 $1.36 --
Diluted EPS (Cont. Ops) $5.47 $0.36 $1.41 $1.36 --
Weighted Average Basic Share $22.4B $22.6B $22.7B $22.7B --
Weighted Average Diluted Share $22.9B $22.7B $22.8B $22.8B --
 
EBITDA $43.1B $11.1B $24.1B $18.6B --
EBIT $38B $4.8B $17.1B $17.4B --
 
Revenue (Reported) $100.3B $59.6B $63.6B $62.6B --
Operating Income (Reported) $38B $4.8B $17.1B $17.4B --
Operating Income (Adjusted) $38B $4.8B $17.1B $17.4B --
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $31.1B $22.7B $12.7B $20.5B --
Short Term Investments $29.1B $22.3B $9.8B $19.4B --
Accounts Receivable, Net $11.5B $11B $11.6B $11.5B --
Inventory $9.1B $9B $10.2B $10.9B --
Prepaid Expenses -- -- -- -- --
Other Current Assets $3.8B $5B $4.9B $4.3B --
Total Current Assets $59.7B $51.3B $43.3B $50.4B --
 
Property Plant And Equipment $17.7B $19.3B $21.9B $20.7B --
Long-Term Investments $21.5B $15.4B $15.8B $2.7B --
Goodwill $49.2B $51.4B $67.8B $68.5B --
Other Intangibles $25.1B $43.4B $64.9B $55.4B --
Other Long-Term Assets $7.7B $13.2B $12.5B $9.8B --
Total Assets $181.5B $197.2B $226.5B $213.4B --
 
Accounts Payable $5.6B $6.8B $6.7B $5.6B --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $2.2B $2.9B $2.4B $4.5B --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $24.9B $22.6B $20.5B $19.7B --
Total Current Liabilities $42.7B $42.1B $47.8B $43B --
 
Long-Term Debt $38.7B $35.5B $64.2B $59.7B --
Capital Leases -- -- -- -- --
Total Liabilities $104B $101.3B $137.2B $124.9B --
 
Common Stock $473M $476M $478M $480M --
Other Common Equity Adj $119M -$412M -$217M $57M --
Common Equity $77.2B $95.7B $89B $88.2B --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $262M $256M $274M $294M --
Total Equity $77.5B $95.9B $89.3B $88.5B --
 
Total Liabilities and Equity $181.5B $197.2B $226.5B $213.4B --
Cash and Short Terms $31.1B $22.7B $12.7B $20.5B --
Total Debt $40.3B $38B $66.4B $63.4B --
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $31.1B $22.7B $12.7B $20.5B --
Short Term Investments $29.1B $22.3B $9.8B $19.4B --
Accounts Receivable, Net $11.5B $11B $11.6B $11.5B --
Inventory $9.1B $9B $10.2B $10.9B --
Prepaid Expenses -- -- -- -- --
Other Current Assets $3.8B $5B $4.9B $4.3B --
Total Current Assets $59.7B $51.3B $43.3B $50.4B --
 
Property Plant And Equipment $17.7B $19.3B $21.9B $20.7B --
Long-Term Investments $21.5B $15.4B $15.8B $2.7B --
Goodwill $49.2B $51.4B $67.8B $68.5B --
Other Intangibles $25.1B $43.4B $64.9B $55.4B --
Other Long-Term Assets $7.7B $13.2B $12.5B $9.8B --
Total Assets $181.5B $197.2B $226.5B $213.4B --
 
Accounts Payable $5.6B $6.8B $6.7B $5.6B --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $2.2B $2.9B $2.4B $4.5B --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $24.9B $22.6B $20.5B $19.7B --
Total Current Liabilities $42.7B $42.1B $47.8B $43B --
 
Long-Term Debt $38.7B $35.5B $64.2B $59.7B --
Capital Leases -- -- -- -- --
Total Liabilities $104B $101.3B $137.2B $124.9B --
 
Common Stock $473M $476M $478M $480M --
Other Common Equity Adj $119M -$412M -$217M $57M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $262M $256M $274M $294M --
Total Equity $77.5B $95.9B $89.3B $88.5B --
 
Total Liabilities and Equity $181.5B $197.2B $226.5B $213.4B --
Cash and Short Terms $31.1B $22.7B $12.7B $20.5B --
Total Debt $40.3B $38B $66.4B $63.4B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $9.2B $22B $31.4B $2.2B $8.1B
Depreciation & Amoritzation $4.7B $5.2B $5.1B $6.3B $7B
Stock-Based Compensation $755M $1.2B $872M $525M $877M
Change in Accounts Receivable -$1.3B -$3.8B $261M $347M -$109M
Change in Inventories -$778M -$1.1B $592M -$1.2B -$854M
Cash From Operations $14.4B $32.6B $33.2B $8.7B $12.7B
 
Capital Expenditures $2.2B $2.7B $3.2B $3.9B $2.9B
Cash Acquisitions -- -- $23B $43.4B --
Cash From Investing -$4.3B -$22.5B -$19.7B -$32.3B $2.7B
 
Dividends Paid (Ex Special Dividend) $8.4B $8.7B $9B $9.2B $9.5B
Special Dividend Paid
Long-Term Debt Issued $17.6B $997M $3.9B $38.5B $8.9B
Long-Term Debt Repaid -$30.3B -$2.1B -$7.4B -$2.6B -$16.1B
Repurchase of Common Stock -- -- $2B -- --
Other Financing Activities -$445M $16M -$335M -$632M -$469M
Cash From Financing -$9.6B -$9.8B -$14.8B $26.1B -$17.1B
 
Beginning Cash (CF) $1.8B $1.9B $416M $2.9B $1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $475M $159M -$1.5B $2.4B -$1.8B
Ending Cash (CF) $2.3B $2B -$1.3B $5.3B -$833M
 
Levered Free Cash Flow $12.2B $29.9B $30B $4.8B $9.8B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $3.4B $5B -$3.4B $418M --
Depreciation & Amoritzation $1.3B $1.5B $1.7B $1.8B --
Stock-Based Compensation $496M $364M $121M $177M --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $5.9B $8.6B $5.2B $6.7B --
 
Capital Expenditures $1B $1B $1B $917M --
Cash Acquisitions -- $16.8B $43.4B -- --
Cash From Investing -$2.6B -$4.4B -$11B -$1.6B --
 
Dividends Paid (Ex Special Dividend) $2.2B $2.2B $2.3B $2.4B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -$265M -$866M $7.7B $732M --
Long-Term Debt Repaid -$1.1B -$1.9B $103M -$3.5B --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $201M $7M -$18M -$14M --
Cash From Financing -$3.4B -$5B $5.4B -$5.1B --
 
Beginning Cash (CF) $1.9B $416M $2.9B $1B --
Foreign Exchange Rate Adjustment -$27M -$26M -$1M -$29M --
Additions / Reductions -$50M -$869M -$315M -$45M --
Ending Cash (CF) $1.9B -$479M $2.5B $969M --
 
Levered Free Cash Flow $4.9B $7.6B $4.2B $5.8B --
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $22B $31.4B $2.2B $8.1B --
Depreciation & Amoritzation $5.2B $5.1B $6.3B $7B --
Stock-Based Compensation $1.2B $872M $525M $877M --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $32.6B $33.2B $8.7B $12.7B --
 
Capital Expenditures $2.7B $3.2B $3.9B $2.9B $1.8B
Cash Acquisitions -- $23B $43.4B -- --
Cash From Investing -$22.5B -$19.7B -$32.3B $2.7B --
 
Dividends Paid (Ex Special Dividend) $8.7B $9B $9.2B $9.5B --
Special Dividend Paid
Long-Term Debt Issued -- $3.9B $38.5B $8.9B --
Long-Term Debt Repaid -$2.1B -$7.4B -$2.6B -$16.1B --
Repurchase of Common Stock -- $2B -- -- --
Other Financing Activities $16M -$335M -$632M -$469M --
Cash From Financing -$9.8B -$14.8B $26.1B -$17.1B --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $159M -$1.5B $2.4B -$1.8B --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $29.9B $30B $4.8B $9.8B --
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Net Income to Stockholders $31.4B $2.2B $8.1B $9.4B --
Depreciation & Amoritzation $5.1B $6.3B $7B $4.9B --
Stock-Based Compensation $872M $525M $877M $574M --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $33.2B $8.7B $12.7B $6.4B --
 
Capital Expenditures $3.2B $3.9B $2.9B $1.8B --
Cash Acquisitions $23B $43.4B -- -- --
Cash From Investing -$19.7B -$32.3B $2.7B $4.8B --
 
Dividends Paid (Ex Special Dividend) $9B $9.2B $9.5B $7.3B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $3.9B $38.5B $8.9B $3.7B --
Long-Term Debt Repaid -$7.4B -$2.6B -$16.1B -$6.9B --
Repurchase of Common Stock $2B -- -- -- --
Other Financing Activities -$335M -$632M -$469M -$376M --
Cash From Financing -$14.8B $26.1B -$17.1B -$10.9B --
 
Beginning Cash (CF) $6B $10.8B $3.9B $4.4B --
Foreign Exchange Rate Adjustment -$165M -$40M -$66M $36M --
Additions / Reductions -$1.5B $2.4B -$1.8B $287M --
Ending Cash (CF) $4.3B $13.2B $2B $4.7B --
 
Levered Free Cash Flow $30B $4.8B $9.8B $4.6B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
77
CPS alert for Feb 14

Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.

Buy
58
TPH alert for Feb 14

Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.

Sell
20
IRON alert for Feb 14

Disc Medicine, Inc. [IRON] is down 21.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock